Prestige Consumer Healthcare Inc. (PBH)
| Market Cap | 2.63B |
| Revenue (ttm) | 943.37M |
| Net Income (ttm) | 164.68M |
| Shares Out | 50.06M |
| EPS (ttm) | 3.25 |
| PE Ratio | 16.18 |
| Forward PE | 16.21 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 23 |
| Last Price | $52.58 |
| Previous Close | $52.55 |
| Change ($) | 0.03 |
| Change (%) | 0.06% |
| Day's Open | 52.60 |
| Day's Range | 51.85 - 52.82 |
| Day's Volume | 268,614 |
| 52-Week Range | 32.20 - 53.88 |
Prestige Consumer (PBH) expanded its eye care portfolio by acquiring TheraTears and four other brands across the VMS and Cough & Cold categories.
TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced acquisition o...
Prestige Consumer's (PBH) solid e-commerce initiatives, together with its impressive marketing efforts and diverse brands, keep it well placed.
TARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a ...
Prestige Consumer's (PBH) fourth-quarter fiscal 2021 results reflect lower earnings and sales year over year due to pandemic-led disruptions in certain brands and tough comparisons with the year-ago per...
Prestige Brands (PBH) delivered earnings and revenue surprises of 0.00% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2021.
Lower consumption patterns across certain categories and tough year-over-year comparisons might have hurt Prestige Consumer's (PBH) fourth-quarter fiscal 2021 performance.
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Consumer Healthcare (PBH) has been benefiting from a strong e-commerce performance as well as efficient saving efforts.
The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, VSTO, SPB, SWBI, MBUU.
The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, CENT, SPB, MCFT, MBUU.
In anticipation of the Fed's big announcement on interest rates and inflation, Q.ai's Artificial Intelligence has brought you today's top buys.
Prestige Consumer (PBH) has been gaining on strength in the e-commerce business and cost-containment efforts. The company recently raised its guidance for fiscal 2021.
The rise in consumer confidence in February proves that people are showing faith in the economy, which makes it an ideal time to invest in consumer discretionary stocks like Central Garden Pet Company(C...
Prestige Consumer Healthcare (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands...
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands...
Prestige Consumer's (PBH) third-quarter fiscal 2021 results reflect stable consumption for most brands and solid e-commerce growth. However, some brands witness lower consumption amid the pandemic.
Prestige Brands (PBH) delivered earnings and revenue surprises of 5.19% and 2.90%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2020.
Prestige Consumer's (PBH) third-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories as well as higher advertising and marketing costs.
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Staar Surgical Co. (NASD: STAA) will replace Prestige Consumer H...
TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4,...
Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
Growth-focused investors may want to consider the following small-cap stocks as they represent companies whose trailing 12-month pro forma earnings per share improved significantly on a year-over-year b...
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript
Prestige Consumer's (PBH) second-quarter fiscal 2021 results reflect stable consumption for most brands and robust e-commerce growth. However, some brands see lower consumption amid the pandemic.
Prestige Brands (PBH) delivered earnings and revenue surprises of 8.33% and 4.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2020.
Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.
TARRYTOWN, N.Y., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 second quarter earnings release on Thursday, November 5...
The rise in consumer spending comes despite a decline in personal income.
Prestige Consumer Healthcare (PBH) has been gaining from its focus on healthcare. Apart from this, the company's e-commerce investments and cost-management efforts look impressive.
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
With no signs of a vaccine yet, fears continue to haunt in spite of strict safety guidelines like social distancing and isolation, and a more cautious approach by people in general.
Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q1 2021 Results - Earnings Call Transcript
Prestige Consumer's (PBH) Q1 results gain from solid e-commerce performance and strong free cash flow amid the ongoing pandemic.
Prestige Brands (PBH) delivered earnings and revenue surprises of 22.86% and 3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
TARRYTOWN, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2020.
Impacts of reversal in coronavirus-induced stockpiling trends are like to get reflected in Prestige Consumer's (PBH) first-quarter fiscal 2021 performance.
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Major tech giants Amazon and Microsoft will be declaring their quarterly results later this week, and while estimates are reduced, expectations in the market are climbing. Our deep learning algorithms h...
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6,...
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?
PBH vs. UNICY: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q4 2020 Results - Earnings Call Transcript
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG ora... [Read more...]
| Industry Medical Distribution | IPO Date Feb 10, 2005 |
| Stock Exchange NYSE | Ticker Symbol PBH |
Financial Performance
In 2020, PBH's revenue was $943.37 million, a decrease of -2.04% compared to the previous year's $963.01 million. Earnings were $164.68 million, an increase of 15.74%.
Analyst Forecasts
According to 7 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 54.75, which is an increase of 4.13% from the latest price.